The Fed stood still, and the floor moved.
Read the dissents, not the decision — half the committee wanted a hike. The market spent 2026 positioned for the next move being down; Wednesday it met a committee arguing the next move is up. Action: REINFORCE the defensive tilt and the short-duration bill ladder; AVOID adding long-duration bonds into a committee debating hikes.
A manta ray is coming for Boeing.
Washington put $3 billion behind a windowless, blended-wing jet — the biggest change in airliner design since the Concorde.
Governments have decided aviation duopolies are a strategic risk, and they are funding the challenger directly — the same pattern as the chips.
The consumer kept swiping through all of it.
The Dow lost 1,153 points. The swipe data never noticed.
Visa is the book’s cleanest expression of employed America: a toll on nominal spending, with no inventory and no credit risk.
P&G just handed us the oil hedge’s receipt.
P&G says the Iran war will cost it $1 billion — in raw materials, freight and surcharges.
This is the receipt for the defensive tilt: P&G pays $90 Brent so that the energy sleeve can collect it.
The $20.6 million 401(k) was legal the whole time.
Nearly 12,000 taxpayers now hold retirement accounts worth $10 million or more. Every step they took was legal.
The likeliest page in this week’s paper to change a client’s life — and most people never asked the five-minute HR question that unlocks it.
The subsidy propping up Medicare drug plans is going away.
The subsidy holding Part D premiums down is sunsetting — a 2027 price shock announced in a 2026 press release.
Health care is the retirement plan’s silent second mortgage, and the rate just went up. Re-shop Part D this fall; do not renew by default.
The miracle drug is now a line item on your Medicare bill.
The miracle drug is now a line item on your Medicare bill.
Same drug class, same calendar, sixteen points apart — Lilly up 14.3% against Novo down 2.2%. That is a franchise war with a winner.
Our oil thesis just ran a live-fire drill.
WTI ran $89.31 to $79.26 and back to $84.46 in five sessions — the same war, read three different ways.
A $10 round trip is our floor-and-ceiling thesis stress-tested in public — and the energy sleeve was the book’s only natural hedge on the worst day of the summer.
Meta asked Wall Street to pick up the AI tab.
Meta went to the bond market to fund the AI build-out. The bond market raised the price.
The pair trade inside the megacaps is finally visible: sellers of AI, who have subscribers, against spenders on AI, who have invoices.
The Pentagon just placed a $120 billion restock order.
A $120 billion munitions restock order — the largest since the Cold War.
A war that empties the magazine is a multi-year revenue commitment to whoever refills it — and this one is funded by an appropriation, not a bond deal.
The private bank approved the mortgages. The banker asked questions later.
The private bank approved the mortgages. The banker asked the questions afterward.
Every cycle has a chapter where the incentives inside a wealth machine quietly outvote its controls — and it is never about one client.
Beijing became oil’s biggest problem.
China cut crude imports 40% — and capped the rally without firing a shot.
This is the strongest argument against our own oil thesis, and we would rather print it than hide from it.
SK Hynix made $64 billion and the stock fell 10%.
SK Hynix earned a record $64 billion. The stock fell 10% anyway.
When perfect earnings get sold, the market is not grading the quarter — it is grading the durability of the boom.
Parsons, Kansas may bury a nuclear reactor a mile underground.
855 CEOs, twenty years, one lesson.
Elon Musk’s tunnel company is worth $20 billion now.
Fauci took the Fifth.
The most dangerous room in the house.
Poor countries are aging fast, and can’t afford it.
The flashy travel card, audited.
